Re:Researchers find a treatable indicator of blood clotting ...
by mikeyouse on Monday December 13, 2021 @11:34AM
(#29541144)
Yep - it was clear from the beginning that hospitalized patients throw a ton of clots, so it's been in the guidelines since 2020 to treat anyone presenting with Covid symptoms with prophylactic thinners;
> Hospitalized nonpregnant adults with COVID-19 should receive prophylactic dose anticoagulation (AIII) (see the recommendations for pregnant individuals below). Anticoagulant or antiplatelet therapy should not be used to prevent arterial thrombosis outside of the usual standard of care for patients without COVID-19 (AIII).
From what I understand, there doesn't seem to be much benefit for overall treatment of the disease (e.g. sick people's lungs don't get better more quickly) but it's preventing tons of PEs and strokes so that's obviously very valuable.
https://www.covid19treatmentguidelines.nih.gov/therapies/ant...
Re:Researchers find a treatable indicator of blood clotting ...
by DnDGrognard on Monday December 13, 2021 @12:32PM
(#29541898)
When I have been in hospital (UK) I was given heparin anyway this seems to be SOP for the NHS
Re:Researchers find a treatable indicator of blood clotting ...
by mgarfias on Monday December 13, 2021 @12:30PM
(#29541866)
I was thinking more like the affect of thinners already in use on a person (such as myself) if they get the rona, and how it affects disease progression.
Re:Researchers find a treatable indicator of blood clotting ...
by DnDGrognard on Monday December 13, 2021 @12:33PM
(#29541919)
Well I am on aspirin and when I got Covid in october (whilst in hospital for something else) my case was rather mild
Re:Researchers find a treatable indicator of blood clotting ...
by cheaprentalyeti on Monday December 13, 2021 @02:05PM
(#29543068)
Go see the links I posted upstream.
"In response to a number of reports that anticoagulant therapy with heparin leads to better prognosis in COVID-19 patients, both domestic and international organizations have issued clinical practice guidelines recommending that all hospitalized COVID-19 patients should receive thromboprophylaxis (mainly heparin treatment) even without clear symptoms of thrombotic complications and understanding their efficacy."